PTPN11 and malignant colon neoplasm: The second strongest interactor was lovastatin, an agonist of Src homology-2 domain-containing protein tyrosine phosphatase-2 (SHP2) that was found to significantly enhance the efficacy of chemotherapy in colon cancer (Wei et al., 2021).